List of works - Rita Campanelli

CD14(bright)CD16(low) intermediate monocytes expressing Tie2 are increased in the peripheral blood of patients with primary myelofibrosis

scientific article

Circulating CD34+, CD133+, and Vascular Endothelial Growth Factor Receptor 2–Positive Endothelial Progenitor Cells in Myelofibrosis With Myeloid Metaplasia

Circulating endothelial progenitor cells in preterm infants with bronchopulmonary dysplasia.

scientific article published on 2 July 2009

Clinical Applications of Mesenchymal Stem/Stromal Cell Derived Extracellular Vesicles: Therapeutic Potential of an Acellular Product

scientific article published on 24 November 2020

Constitutive Store-Operated Ca(2+) Entry Leads to Enhanced Nitric Oxide Production and Proliferation in Infantile Hemangioma-Derived Endothelial Colony-Forming Cells

scientific article published on 9 December 2015

Cytotoxic T-lymphocyte responses in melanoma through in vitro stimulation with the Melan-A peptide analogue A27L: a qualitative analysis

article

Different subsets of circulating angiogenic cells do not predict bronchopulmonary dysplasia or other diseases of prematurity in preterm infants

scientific article published on 01 July 2013

Differential recognition of heat-shock protein dnaJ-derived epitopes by effector and Treg cells leads to modulation of inflammation in juvenile idiopathic arthritis.

scientific article published in May 2007

Dominant TCR-alpha requirements for a self antigen recognition in humans

scientific article (publication date: December 2002)

Early haemoglobin-independent increase of plasma erythropoietin levels in patients with acute myocardial infarction

scientific article published on 05 April 2007

Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker

scientific article published on 23 July 2009

Evaluation of the bioactive and total transforming growth factor β1 levels in primary myelofibrosis.

scientific article published on 30 August 2010

Evidence that prefibrotic myelofibrosis is aligned along a clinical and biological continuum featuring primary myelofibrosis

scientific article

Functional and genetic aberrations of in vitro-cultured marrow-derived mesenchymal stromal cells of patients with classical Philadelphia-negative myeloproliferative neoplasms

scientific article published on 12 March 2014

High frequency of endothelial colony forming cells marks a non-active myeloproliferative neoplasm with high risk of splanchnic vein thrombosis

scientific article

High-dose erythropoietin in patients with acute myocardial infarction: A pilot, randomised, placebo-controlled study

scientific article published on 10 November 2009

Human CD8 co–receptor is strictly involved in MHC–peptide tetramer–TCR binding and T cell activation

scientific article published on 01 January 2002

Increase of circulating endothelial cells in patients with Hereditary Hemorrhagic Telangiectasia.

scientific article published on 3 December 2014

Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction

scientific article published on 02 September 2004

Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis.

scientific article

Involvement of TGFβ1 in autocrine regulation of proplatelet formation in healthy subjects and patients with primary myelofibrosis

scientific article published on 12 February 2013

JAK2 V617F genotype is a strong determinant of blast transformation in primary myelofibrosis

scientific article

JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis.

scientific article published on 21 August 2007

JAK2(V617F) allele burden ⩾50% is associated with response to ruxolitinib in persons with MPN-associated myelofibrosis and splenomegaly requiring therapy.

scientific article published on 29 February 2016

Molecular and functional bases of self-antigen recognition in long-term persistent melanocyte-specific CD8+ T cells in one vitiligo patient

scientific article published in August 2003

No association between the XPD Lys751Gln (rs13181) polymorphism and disease phenotype or leukemic transformation in primary myelofibrosis.

scientific article published on 28 May 2013

Phase I/II study of single-agent bortezomib for the treatment of patients with myelofibrosis. Clinical and biological effects of proteasome inhibition

scientific article

Primary myelofibrosis: Older age and high JAK2V617F allele burden are associated with elevated plasma high-sensitivity C-reactive protein levels and a phenotype of progressive disease.

scientific article published on 7 June 2017

Rapid and large increase of the frequency of circulating endothelial colony-forming cells (ECFCs) generating late outgrowth endothelial cells in patients with acute myocardial infarction

scientific article published on 13 November 2008

Rapid and long-lasting decrease of T-regulatory cells in patients with myelofibrosis treated with ruxolitinib.

scientific article published on 22 October 2013

Reduced frequency of circulating CD4+CD25brightCD127lowFOXP3+ regulatory T cells in primary myelofibrosis.

scientific article published on 16 August 2016

Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo.

scientific article

Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation.

scientific article

Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasia

scientific article published in March 2004

Splenectomy produces a rapid but transient decrease of the frequency of circulating CD34+ haematopoietic progenitor cells in primary myelofibrosis

scientific article published on 23 January 2011

Stem cells for bronchopulmonary dysplasia and intraventricular haemorrhage repair in preterm infants

scientific article published on 01 May 2012

The expression of CXCR4 is down-regulated on the CD34+ cells of patients with myelofibrosis with myeloid metaplasia

scientific article

The spleen of patients with myelofibrosis harbors defective mesenchymal stromal cells

scientific article

Tie2 Expressing Monocytes in the Spleen of Patients with Primary Myelofibrosis

scientific article

Vascular endothelial growth factor promoted endothelial progenitor cell mobilization into the peripheral blood of a patient with POEMS syndrome

scientific article published on 01 September 2007

List of works by Rita Campanelli

CD14(bright)CD16(low) intermediate monocytes expressing Tie2 are increased in the peripheral blood of patients with primary myelofibrosis

Circulating CD34+, CD133+, and Vascular Endothelial Growth Factor Receptor 2–Positive Endothelial Progenitor Cells in Myelofibrosis With Myeloid Metaplasia

Circulating endothelial progenitor cells in preterm infants with bronchopulmonary dysplasia.

Clinical Applications of Mesenchymal Stem/Stromal Cell Derived Extracellular Vesicles: Therapeutic Potential of an Acellular Product

Constitutive Store-Operated Ca(2+) Entry Leads to Enhanced Nitric Oxide Production and Proliferation in Infantile Hemangioma-Derived Endothelial Colony-Forming Cells

Cytotoxic T-lymphocyte responses in melanoma through in vitro stimulation with the Melan-A peptide analogue A27L: a qualitative analysis

Different subsets of circulating angiogenic cells do not predict bronchopulmonary dysplasia or other diseases of prematurity in preterm infants

Differential recognition of heat-shock protein dnaJ-derived epitopes by effector and Treg cells leads to modulation of inflammation in juvenile idiopathic arthritis.

Dominant TCR-alpha requirements for a self antigen recognition in humans

Early haemoglobin-independent increase of plasma erythropoietin levels in patients with acute myocardial infarction

Endothelial colony-forming cells from patients with chronic myeloproliferative disorders lack the disease-specific molecular clonality marker

Evaluation of the bioactive and total transforming growth factor β1 levels in primary myelofibrosis.

Evidence that prefibrotic myelofibrosis is aligned along a clinical and biological continuum featuring primary myelofibrosis

Functional and genetic aberrations of in vitro-cultured marrow-derived mesenchymal stromal cells of patients with classical Philadelphia-negative myeloproliferative neoplasms

High frequency of endothelial colony forming cells marks a non-active myeloproliferative neoplasm with high risk of splanchnic vein thrombosis

High-dose erythropoietin in patients with acute myocardial infarction: A pilot, randomised, placebo-controlled study

Human CD8 co–receptor is strictly involved in MHC–peptide tetramer–TCR binding and T cell activation

Increase of circulating endothelial cells in patients with Hereditary Hemorrhagic Telangiectasia.

Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction

Increased plasma nicotinamide phosphoribosyltransferase is associated with a hyperproliferative phenotype and restrains disease progression in MPN-associated myelofibrosis.

Involvement of TGFβ1 in autocrine regulation of proplatelet formation in healthy subjects and patients with primary myelofibrosis

JAK2 V617F genotype is a strong determinant of blast transformation in primary myelofibrosis

JAK2 V617F mutational status predicts progression to large splenomegaly and leukemic transformation in primary myelofibrosis.

JAK2(V617F) allele burden ⩾50% is associated with response to ruxolitinib in persons with MPN-associated myelofibrosis and splenomegaly requiring therapy.

Molecular and functional bases of self-antigen recognition in long-term persistent melanocyte-specific CD8+ T cells in one vitiligo patient

No association between the XPD Lys751Gln (rs13181) polymorphism and disease phenotype or leukemic transformation in primary myelofibrosis.

Phase I/II study of single-agent bortezomib for the treatment of patients with myelofibrosis. Clinical and biological effects of proteasome inhibition

Primary myelofibrosis: Older age and high JAK2V617F allele burden are associated with elevated plasma high-sensitivity C-reactive protein levels and a phenotype of progressive disease.

Rapid and large increase of the frequency of circulating endothelial colony-forming cells (ECFCs) generating late outgrowth endothelial cells in patients with acute myocardial infarction

Rapid and long-lasting decrease of T-regulatory cells in patients with myelofibrosis treated with ruxolitinib.

Reduced frequency of circulating CD4+CD25brightCD127lowFOXP3+ regulatory T cells in primary myelofibrosis.

Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo.

Spleen endothelial cells from patients with myelofibrosis harbor the JAK2V617F mutation.

Spleen neoangiogenesis in patients with myelofibrosis with myeloid metaplasia

Splenectomy produces a rapid but transient decrease of the frequency of circulating CD34+ haematopoietic progenitor cells in primary myelofibrosis

Stem cells for bronchopulmonary dysplasia and intraventricular haemorrhage repair in preterm infants

The expression of CXCR4 is down-regulated on the CD34+ cells of patients with myelofibrosis with myeloid metaplasia

The spleen of patients with myelofibrosis harbors defective mesenchymal stromal cells

Tie2 Expressing Monocytes in the Spleen of Patients with Primary Myelofibrosis

Vascular endothelial growth factor promoted endothelial progenitor cell mobilization into the peripheral blood of a patient with POEMS syndrome